Intraoperative Infusion of Dexmedetomidine for Prevention of Postoperative Delirium in Elderly Patients

Recruiting N/A Interventional Study
Dexmedetomidine Postoperative Delirium
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
420 (estimated)
Sponsor
Beijing Tiantan Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Postoperative delirium (POD) is a common surgical complication. The incidence is 10% to 22% in neurological procedures, and advanced age is a risk factor for neurological procedures. Many studies have shown that dexmedetomidine(DEX) may reduce the incidence of delirium in non-cardiac surgery patients and elderly patients. However, there are few studies focus on the effect of DEX on POD in elderly …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients undergoing selective craniotomy. * Age ≥65 years. * Obtain written informed consent. Exclusion Criteria: * Operation time less than 2 hours. * Refusal to provide written informed consent. * Cognitive impairment before surgery(mini-mental state examination, MMSE ≤ 26…
Contacts

Yuming Peng, MD,Ph.D

8610-59976658

florapym766@163.com

CONTACT